Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...
Enregistré dans:
Auteurs principaux: | Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d30df532fce74d6d8dfcbb518f2a4ae4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
par: Ekaterina E. Mishina, et autres
Publié: (2017) -
EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
par: A. V. Bogolyubova, et autres
Publié: (2019) -
Association of insulin resistance and non-alcoholic fatty liver disease
par: Ekaterina E. Mishina, et autres
Publié: (2021) -
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
par: Filip R, et autres
Publié: (2018) -
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
par: Shahinul Alam, et autres
Publié: (2021)